Concordia Pharma Gets False Ad Trial Award Upped to $2.2M – Law360

Lloyd Smith, Shareholder in the firm’s Intellectual Property section, was quoted in Law360’s article "Concordia Pharma Gets False Ad Trial Award Upped to $2.2M" following an opinion trebling damages in the Concordia v. Method case the team won last year at a jury trial. The team, led by Lloyd Smith and Samuel Braver, Shareholders in Intellectual Property and Litigation, respectively, includes James Wilcox and Laura Pitts, Associates in Intellectual Property.

The case was also covered by BloombergBNA Pharmaceutical Law & Industry Report.